Insider · CIK 0001507111
Ronald M. Lombardi
directorceoofficer
Files at ACCO (ACCO BRANDS Corp), PBH (Prestige Consumer Healthcare Inc.). First filing Nov 19, 2024, latest Nov 21, 2024.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $7.7M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PBH: Prestige Consumer Healthcare Inc.
PBHOct 9, 2026 · close 48.23
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 49Moderate | Prestige Consumer Healthcare Inc. | $898k 10,875 shares | -3% | - | |
| 55Moderate | Prestige Consumer Healthcare Inc. | $6.8M 82,237 shares | -22% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 9, 2026 | ACCO ACCO BRANDS Corp | AGrant or award Restricted Stock Unitsderivative | +3,292 | $0.00 | $0 | 192,913 | 32 d ago |
| Mar 26, 2026 | ACCO ACCO BRANDS Corp | AGrant or award Restricted Stock Unitsderivative | +3,787 | $0.00 | $0 | 153,252 | Mar 27, 2026 |
| Dec 10, 2025 | ACCO ACCO BRANDS Corp | AGrant or award Restricted Stock Unitsderivative | +2,962 | $0.00 | $0 | 149,465 | Dec 11, 2025 |
| Sep 10, 2025 | ACCO ACCO BRANDS Corp | AGrant or award Restricted Stock Unitsderivative | +2,716 | $0.00 | $0 | 146,503 | Sep 12, 2025 |
| Jun 18, 2025 | ACCO ACCO BRANDS Corp | AGrant or award Restricted Stock Unitsderivative | +3,077 | $0.00 | $0 | 143,787 | Jun 20, 2025 |
| May 20, 2025 | ACCO ACCO BRANDS Corp | AGrant or award Restricted Stock Unitsderivative | +32,895 | $0.00 | $0 | 140,710 | May 21, 2025 |
| May 7, 2025 | PBH Prestige Consumer Healthcare Inc. | FTax withholding Common Stock, par value $0.01 per share | -2,305 | $81.41 | $188k | 346,529 | May 9, 2025 |
| May 5, 2025 | PBH Prestige Consumer Healthcare Inc. | AGrant or award Common Stock, par value $0.01 per share | +12,352 | $0.00 | $0 | 348,834 | May 7, 2025 |
| May 2, 2025 | PBH Prestige Consumer Healthcare Inc. | FTax withholding Common Stock, par value $0.01 per share | -2,664 | $84.19 | $224k | 318,288 | May 6, 2025 |
| May 2, 2025 | PBH Prestige Consumer Healthcare Inc. | FTax withholding Common Stock, par value $0.01 per share | -2,416 | $84.19 | $203k | 315,872 | May 6, 2025 |
| May 5, 2025 | PBH Prestige Consumer Healthcare Inc. | AGrant or award Common Stock, par value $0.01 per share | +39,904 | $0.00 | $0 | 355,776 | May 6, 2025 |
| May 5, 2025 | PBH Prestige Consumer Healthcare Inc. | FTax withholding Common Stock, par value $0.01 per share | -19,294 | $82.98 | $1.6M | 336,482 | May 6, 2025 |
| Mar 26, 2025 | ACCO ACCO BRANDS Corp | AGrant or award Restricted Stock Unitsderivative | +1,811 | $0.00 | $0 | 107,815 | Mar 27, 2025 |
| Dec 11, 2024 | ACCO ACCO BRANDS Corp | AGrant or award Restricted Stock Unitsderivative | +1,283 | $0.00 | $0 | 106,004 | Dec 12, 2024 |
| Nov 19, 2024 | PBH Prestige Consumer Healthcare Inc. | MOption exercise Common Stock, par value $0.01 per share | +5,213 | $57.18 | $298k | 326,165 | Nov 21, 2024 |
| Nov 19, 2024 | PBH Prestige Consumer Healthcare Inc. | SOpen-market sale Common Stock, par value $0.01 per share | -5,213 | $82.55 | $430k | 320,952 | Nov 21, 2024 |
| Nov 19, 2024 | PBH Prestige Consumer Healthcare Inc. | MOption exercise Common Stock, par value $0.01 per share | +5,662 | $56.11 | $318k | 326,614 | Nov 21, 2024 |
| Nov 19, 2024 | PBH Prestige Consumer Healthcare Inc. | SOpen-market sale Common Stock, par value $0.01 per share | -5,662 | $82.64 | $468k | 320,952 | Nov 21, 2024 |
| Nov 19, 2024 | PBH Prestige Consumer Healthcare Inc. | MOption exercise Employee Stock Options (right to buy)derivative | -5,213 | $0.00 | $0 | 0 | Nov 21, 2024 |
| Nov 19, 2024 | PBH Prestige Consumer Healthcare Inc. | MOption exercise Employee Stock Options (right to buy)derivative | -5,662 | $0.00 | $0 | 0 | Nov 21, 2024 |
| Nov 18, 2024 | PBH Prestige Consumer Healthcare Inc. | MOption exercise Common Stock, par value $0.01 per share | +48,512 | $57.18 | $2.8M | 369,464 | Nov 19, 2024 |
| Nov 18, 2024 | PBH Prestige Consumer Healthcare Inc. | SOpen-market sale Common Stock, par value $0.01 per share | -48,512 | $82.67 | $4.0M | 320,952 | Nov 19, 2024 |
| Nov 18, 2024 | PBH Prestige Consumer Healthcare Inc. | MOption exercise Common Stock, par value $0.01 per share | +33,725 | $56.11 | $1.9M | 354,677 | Nov 19, 2024 |
| Nov 18, 2024 | PBH Prestige Consumer Healthcare Inc. | SOpen-market sale Common Stock, par value $0.01 per share | -33,725 | $82.41 | $2.8M | 320,952 | Nov 19, 2024 |
| Nov 18, 2024 | PBH Prestige Consumer Healthcare Inc. | MOption exercise Employee Stock Options (right to buy)derivative | -48,512 | $0.00 | $0 | 5,213 | Nov 19, 2024 |
| Nov 18, 2024 | PBH Prestige Consumer Healthcare Inc. | MOption exercise Employee Stock Options (right to buy)derivative | -33,725 | $0.00 | $0 | 5,662 | Nov 19, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.